SATT Conectus Alsace SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SATT Conectus Alsace SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10534
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SATT Conectus Alsace SAS (Conectus Alsace), a subsidiary of SATT Association, is a technology transfer service provider. The company offers services such as single entry point, well-defined research collaborations, technology transfers, accessible technology platforms, license approach, indexing, sensitization and training; management of IP rights and commercialization; investment, skills mapping, monitoring, contract management, platform management, and others. It provides accessible technology platforms for assessment of client analyses and evaluations. The company serves researchers and deal makers in health and life sciences, chemicals materials, engineering sciences, information and communication technology areas. Conectus Alsace is headquartered in Strasbourg, France.

SATT Conectus Alsace SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Lysogene Enters into Agreement with Institute of Genetics and Molecular and Cellular Biology (IGBMC) and SATT Conectus 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Conectus Alsace Enters into Co-Development Agreement with PEP-Therapy 13
Licensing Agreements 14
SATT Conectus Alsace Enters into License Agreement with Syndivia 14
SATT Conectus Alsace SAS – Key Competitors 15
SATT Conectus Alsace SAS – Key Employees 16
SATT Conectus Alsace SAS – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Key Facts 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT Conectus Alsace SAS, Deals By Therapy Area, 2012 to YTD 2018 8
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lysogene Enters into Agreement with Institute of Genetics and Molecular and Cellular Biology (IGBMC) and SATT Conectus 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Conectus Alsace Enters into Co-Development Agreement with PEP-Therapy 13
SATT Conectus Alsace Enters into License Agreement with Syndivia 14
SATT Conectus Alsace SAS, Key Competitors 15
SATT Conectus Alsace SAS, Key Employees 16

List of Figures
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SATT Conectus Alsace SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ballast Nedam NV:企業の戦略・SWOT・財務情報
    Ballast Nedam NV - Strategy, SWOT and Corporate Finance Report Summary Ballast Nedam NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cafes Novell SA:企業の戦略・SWOT・財務分析
    Cafes Novell SA - Strategy, SWOT and Corporate Finance Report Summary Cafes Novell SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Country Road Group Pty Ltd:企業の戦略的SWOT分析
    Country Road Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • United Rentals Inc:戦略・SWOT・企業財務分析
    United Rentals Inc - Strategy, SWOT and Corporate Finance Report Summary United Rentals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • The Seibels Bruce Group, Inc:企業の戦略・SWOT・財務情報
    The Seibels Bruce Group, Inc - Strategy, SWOT and Corporate Finance Report Summary The Seibels Bruce Group, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CVRx Inc-医療機器分野:企業M&A・提携分析
    Summary CVRx Inc (CVRx) is a medical device company that develops and designs implantable device. The company offers barostim neo system, which is designed to trigger the body’s natural blood flow regulation system to treat high blood pressure and heart failure. Its products are used in the treatmen …
  • Mineral Resources Ltd:企業の戦略・SWOT・財務分析
    Mineral Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Mineral Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MSIG Holdings (Asia) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CEZ, AS (CEZ)-エネルギー分野:企業M&A・提携分析
    Summary CEZ, a.s. (CEZ) is an integrated energy conglomerate that extracts and sells coal; generates and distributes electricity and heat; and trades in electricity, natural gas, and other commodities. It generates electricity from nuclear, coal, gas, hydro, solar, wind, and biogas sources. The comp …
  • Amgen Inc (AMGN)-医療機器分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • Cynvenio Biosystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that focuses on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood. The company offers products such as lab automation systems, isolation products and proprietary informat …
  • Cooper-Standard Holdings Inc.:企業の戦略・SWOT・財務情報
    Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Vectura Group Plc (VEC):企業の製品パイプライン分析
    Summary Vectura Group Plc (Vectura) is a formulation, device design and development company. It focuses on the development of inhaled airways products through an integrated inhaled drug delivery platform. Its major products include dry powder inhalers (DPI) and metered dose inhalers (MDI) for patien …
  • Konica Minolta, Inc.:企業の戦略・SWOT・財務情報
    Konica Minolta, Inc. - Strategy, SWOT and Corporate Finance Report Summary Konica Minolta, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析
    LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • National Rural Utilities Cooperative Finance Corporation:企業の戦略・SWOT・財務情報
    National Rural Utilities Cooperative Finance Corporation - Strategy, SWOT and Corporate Finance Report Summary National Rural Utilities Cooperative Finance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • Kier Group plc:企業の戦略・SWOT・財務情報
    Kier Group plc - Strategy, SWOT and Corporate Finance Report Summary Kier Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Veolia Environnement SA (VIE)-エネルギー分野:企業M&A・提携分析
    Summary Veolia Environnement SA (Veolia) is an environmental management services company that designs and offers water, waste and energy management solutions. Its service offerings include wastewater and sanitation services, drinking water treatment and distribution and waste management and energy s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆